MORGAN STANLEY - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$8,896,627
-40.6%
554,652
-14.2%
0.00%0.0%
Q2 2023$14,988,803
+3.2%
646,626
+3.4%
0.00%
-50.0%
Q1 2023$14,528,101
+11.6%
625,402
-30.3%
0.00%
+100.0%
Q4 2022$13,013,743
-0.4%
896,881
+31.0%
0.00%
-50.0%
Q3 2022$13,064,000
+0.2%
684,649
-4.6%
0.00%0.0%
Q2 2022$13,044,000
-10.4%
717,908
+24.2%
0.00%0.0%
Q1 2022$14,561,000
+15.4%
577,848
+26.4%
0.00%0.0%
Q4 2021$12,621,000
-54.6%
457,237
-46.9%
0.00%
-50.0%
Q3 2021$27,825,000
+6.5%
861,738
+0.9%
0.00%
+33.3%
Q2 2021$26,121,000
+14.9%
854,164
+14.4%
0.00%0.0%
Q1 2021$22,728,000
-48.3%
746,404
-66.4%
0.00%
-57.1%
Q4 2020$43,977,000
+325.1%
2,223,868
+180.3%
0.01%
+250.0%
Q3 2020$10,345,000
+6.6%
793,359
-7.3%
0.00%0.0%
Q2 2020$9,701,000
-40.1%
855,462
-24.4%
0.00%
-50.0%
Q1 2020$16,187,000
-68.3%
1,131,246
-39.6%
0.00%
-66.7%
Q4 2019$51,011,000
+142.4%
1,873,285
+154.8%
0.01%
+100.0%
Q3 2019$21,046,000
+60.2%
735,062
+55.5%
0.01%
+100.0%
Q2 2019$13,136,000
+233.7%
472,822
+298.7%
0.00%
+200.0%
Q1 2019$3,937,000
-78.3%
118,589
-81.0%
0.00%
-80.0%
Q4 2018$18,147,000
-46.5%
624,258
-15.3%
0.01%
-37.5%
Q3 2018$33,916,000
+159.6%
737,327
+110.9%
0.01%
+100.0%
Q2 2018$13,065,000
+6.0%
349,635
-16.1%
0.00%
+33.3%
Q1 2018$12,320,000
-13.6%
416,943
+0.5%
0.00%
-25.0%
Q4 2017$14,254,000
+58.0%
415,022
+66.4%
0.00%
+33.3%
Q3 2017$9,022,000
+78.3%
249,377
+27.4%
0.00%
+50.0%
Q2 2017$5,060,000
-51.1%
195,780
-63.6%
0.00%0.0%
Q1 2017$10,338,000
-71.9%
538,376
-75.6%
0.00%
-66.7%
Q4 2016$36,766,000
+24.6%
2,205,508
+53.8%
0.01%
-40.0%
Q3 2016$29,516,000
-24.4%
1,434,173
+12.5%
0.01%
-28.6%
Q2 2016$39,023,000
+59.6%
1,275,274
+95.3%
0.01%
+55.6%
Q1 2016$24,446,000
-7.8%
653,108
+6.3%
0.01%
-10.0%
Q4 2015$26,517,000
+433.2%
614,409
+363.0%
0.01%
+400.0%
Q3 2015$4,973,000
-28.4%
132,707
-35.0%
0.00%0.0%
Q2 2015$6,945,000
+13.1%
204,309
+17.7%
0.00%0.0%
Q1 2015$6,143,000
-44.3%
173,539
-46.4%
0.00%
-50.0%
Q4 2014$11,024,000
-28.9%
323,650
-19.5%
0.00%
-33.3%
Q3 2014$15,510,000
-25.8%
402,126
-25.1%
0.01%
-25.0%
Q2 2014$20,896,000
-17.6%
536,885
-27.6%
0.01%
-27.3%
Q1 2014$25,346,000
+63.7%
741,367
+0.4%
0.01%
+57.1%
Q4 2013$15,486,000
+21.9%
738,207
+36.6%
0.01%
+16.7%
Q3 2013$12,700,000
-23.1%
540,478
-12.1%
0.01%
-25.0%
Q2 2013$16,515,000614,6300.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders